Next Article in Journal
Clinical Significance of IgG Avidity Testing and Other Considerations in the Diagnosis of Congenital Cytomegalovirus Infection: A Review Update
Previous Article in Journal
Acute and Sub-Acute Toxicity Evaluation of the Methanolic Extract of Alstonia scholaris Stem Bark
Open AccessEditorial

Targeting in Cancer Therapies

1
Biomedical Research Institute Sant Pau (IIB-SantPau) and Josep Carreras Leukemia Research Institute, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain
2
CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Bellaterra, 08193 Cerdanyola del Vallès, Spain
3
Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, 08193 Cerdanyola del Vallès, Spain
4
Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, 08193 Cerdanyola del Vallès, Spain
*
Author to whom correspondence should be addressed.
Academic Editor: Yu-Jia Chang
Med. Sci. 2016, 4(1), 6; https://doi.org/10.3390/medsci4010006
Received: 2 March 2016 / Revised: 2 March 2016 / Accepted: 3 March 2016 / Published: 8 March 2016
Note: In lieu of an abstract, this is an excerpt from the first page.

Drug developers recruit and combine principles, procedures and strategies from chemistry, pharmacology, nanotechnology and biotechnology, focusing on the generation of functional vehicles as nano-carriers of drugs for improved stability and enhanced intracellular delivery.[...] View Full-Text
Show Figures

Graphical abstract

MDPI and ACS Style

Mangues, R.; Vázquez, E.; Villaverde, A. Targeting in Cancer Therapies. Med. Sci. 2016, 4, 6.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop